KEGG   PATHWAY: npo04934
Entry
npo04934                    Pathway                                
Name
Cushing syndrome - Nyctereutes procyonoides (raccoon dog)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
npo04934  Cushing syndrome
npo04934

Organism
Nyctereutes procyonoides (raccoon dog) [GN:npo]
Gene
129505285  CRH; corticoliberin [KO:K05256]
129493694  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
129502837  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
129497792  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
129497848  neuroendocrine secretory protein 55 [KO:K04632]
129512833  guanine nucleotide-binding protein G(s) subunit alpha-like isoform X1 [KO:K04632]
129515724  LOW QUALITY PROTEIN: adenylate cyclase type 1-like [KO:K08041] [EC:4.6.1.1]
129516202  adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
129498939  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
129510932  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
129499511  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
129503910  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
129517234  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
129513386  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
129502672  ADCY8; adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
129519450  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
129519960  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
129521768  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
129522997  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
129518269  cyclic AMP-responsive element-binding protein 1-like [KO:K05870]
129498595  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
129511576  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
129508719  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
129494799  CREB3; cyclic AMP-responsive element-binding protein 3 isoform X1 [KO:K09048]
129503105  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
129515926  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
129522278  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 [KO:K09048]
129502771  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
129513003  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
129503198  MEN1; menin isoform X1 [KO:K14970]
129515980  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 [KO:K14964]
129515204  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
129503794  WDR5B; WD repeat-containing protein 5B [KO:K14963]
129510847  WDR5; WD repeat-containing protein 5 [KO:K14963]
129496993  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
129517321  KMT2D; histone-lysine N-methyltransferase 2D isoform X1 [KO:K09187] [EC:2.1.1.354]
129520495  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
129495074  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
129495075  cyclin-dependent kinase inhibitor 2A-like isoform X1 [KO:K06621]
129511485  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
129498092  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
129502968  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
129516428  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
129496621  E2F1; transcription factor E2F1 [KO:K17454]
129514246  E2F2; transcription factor E2F2 [KO:K09389]
129507839  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
129497757  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
129494269  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
129519569  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha-3 [KO:K04630]
129522106  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
129502884  AHR; aryl hydrocarbon receptor [KO:K09093]
129503038  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
129497750  AIPL1; aryl-hydrocarbon-interacting protein-like 1 [KO:K17767]
129501302  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
129517176  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
129511299  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
129501012  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
129495669  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
129497562  G1/S-specific cyclin-E1-like [KO:K06626]
129512989  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
129503382  CACNA1C; LOW QUALITY PROTEIN: voltage-dependent L-type calcium channel subunit alpha-1C [KO:K04850]
129521343  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D [KO:K04851]
129517804  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
129505985  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
129515997  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
129509461  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
129509507  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
129521159  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
129501387  RAP1A; ras-related protein Rap-1A [KO:K04353]
129511430  RAP1B; ras-related protein Rap-1b [KO:K07836]
129515848  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
129506345  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
129522322  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
129502349  mitogen-activated protein kinase 3-like [KO:K04371] [EC:2.7.11.24]
129507918  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
129519082  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
129517389  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
129494118  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
129506337  USP8; ubiquitin carboxyl-terminal hydrolase 8 [KO:K11839] [EC:3.4.19.12]
129511116  POMC; pro-opiomelanocortin [KO:K05228]
129495431  adrenocorticotropic hormone receptor [KO:K04200]
129514502  adrenocorticotropic hormone receptor [KO:K04200]
129502024  MRAP; melanocortin-2 receptor accessory protein [KO:K22398]
129510246  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
129521078  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
129498806  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
129513885  NR5A1; steroidogenic factor 1 [KO:K08560]
129517345  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
129515224  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
129502591  cytochrome P450 11B1, mitochondrial-like isoform X1 [KO:K00497] [EC:1.14.15.4]
129493641  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
129515671  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
129498949  NCEH1; neutral cholesterol ester hydrolase 1 isoform X1 [KO:K14349] [EC:3.1.1.-]
129519969  ARMC5; armadillo repeat-containing protein 5 [KO:K22499]
129499243  AGT; angiotensinogen [KO:K09821]
129507359  AGTR1; type-1 angiotensin II receptor [KO:K04166]
129500644  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
129522061  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
129496894  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
129504276  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
129497646  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
129500550  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
129521608  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
129505465  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
129512495  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
129506035  KCNK2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
129506710  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
129519824  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H [KO:K04855]
129511858  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I [KO:K04856]
129508071  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
129504978  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
129510978  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
129521725  LDLR; low-density lipoprotein receptor [KO:K12473]
129507552  SCARB1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
129506407  cholesterol side-chain cleavage enzyme, mitochondrial [KO:K00498] [EC:1.14.15.6]
129501295  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase [KO:K00070] [EC:1.1.1.145 5.3.3.1]
129513000  steroid 21-hydroxylase isoform X1 [KO:K00513] [EC:1.14.14.16]
129508830  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
129517408  WNT1; proto-oncogene Wnt-1 [KO:K03209]
129501220  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
129502893  WNT2; protein Wnt-2 [KO:K00182]
129506798  WNT3; LOW QUALITY PROTEIN: proto-oncogene Wnt-3 [KO:K00312]
129515047  WNT3A; protein Wnt-3a [KO:K00312]
129513678  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
129503341  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
129521805  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
129523023  WNT6; protein Wnt-6 [KO:K00445]
129511925  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
129521980  WNT7A; protein Wnt-7a [KO:K00572]
129494611  WNT8A; protein Wnt-8a [KO:K00714]
129493561  WNT8B; protein Wnt-8b [KO:K00714]
129500703  WNT9B; protein Wnt-9b [KO:K01064]
129514999  WNT9A; protein Wnt-9a [KO:K01064]
129522994  WNT10A; protein Wnt-10a [KO:K01357]
129517200  WNT10B; protein Wnt-10b [KO:K01357]
129506696  WNT11; protein Wnt-11 [KO:K01384]
129502963  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
129498263  FZD1; frizzled-1 [KO:K02432]
129522877  FZD7; frizzled-7 isoform X1 [KO:K02432]
129510346  FZD2; frizzled-2 [KO:K02235]
129493707  FZD3; frizzled-3 [KO:K02329]
129506743  FZD4; frizzled-4 [KO:K02354]
129499073  FZD8; frizzled-8 [KO:K02375]
129522741  FZD5; LOW QUALITY PROTEIN: frizzled-5 [KO:K02375]
129495713  FZD6; frizzled-6 isoform X1 [KO:K02376]
129508175  FZD10; frizzled-10 [KO:K02842]
129519529  FZD9; frizzled-9 [KO:K02842]
129496981  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
129497764  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
129498669  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
129503652  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
129519365  AXIN1; axin-1 isoform X1 [KO:K02157]
129507164  AXIN2; axin-2 isoform X1 [KO:K04385]
129506984  CTNNB1; catenin beta-1 [KO:K02105]
129519526  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
129521503  APC2; LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085]
129494859  TCF7; transcription factor 7 isoform X1 [KO:K02620]
129510910  TCF7L1; transcription factor 7-like 1 [KO:K04490]
129493862  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
129521205  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
npo00020  Citrate cycle (TCA cycle)
npo00140  Steroid hormone biosynthesis
npo04020  Calcium signaling pathway
npo04024  cAMP signaling pathway
npo04110  Cell cycle
npo04310  Wnt signaling pathway
npo04927  Cortisol synthesis and secretion
npo04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system